GLP-1 RAs linked to increased risk for androgenetic alopecia, nonscarring hair loss, telogen effluvium at 6 months.

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think ...

Following functional endoscopic sinus surgery, adults with chronic rhinosinusitis with nasal polyps and obesity had a lower risk for revision surgery if they were prescribed a GLP-1 receptor agonist, ...

G-protein-coupled receptors (GPCRs) are one of the largest families of cell surface proteins in the human body that recognize hormones, neurotransmitters, and drugs. These receptors regulate a wide ...

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

Enveric Biosciences ENVB on Thursday shared new mechanistic data demonstrating that its lead candidate, EB-003, activates both Gq- and β-arrestin–mediated signaling downstream of the 5-HT₂A receptor.

GLP-1 therapy may lower CKD dementia risk and Alzheimer’s incidence in diabetic patients. Explore the latest evidence and clinical implications.

Combined GLP 1 receptor agonists and progestin therapy reduces endometrial cancer risk and hysterectomy rates in women with benign uterine conditions.

The human body is often described in parts—different limbs, systems, and organs—rather than something fully interconnected and whole. Yet many bodily processes interact in ways we may not always ...

TUCSON, AZ / ACCESS Newswire / February 9, 2026 / Umbrella Labs today announced an expanded research focused program for ...